Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. demonstrates a positive outlook due to its strong performance indicators, including a rental rate growth of 4.1% year-over-year and impressive same-store NOI growth, with the SHOP segment expanding by 25.3% and ISHC by 21.7%. The company has successfully maintained the highest Funds From Operations (FFO) growth rate within the Healthcare REIT industry and expects robust two-year compound annual growth rates (CAGR) for Trilogy and SHOP, projected at 11.8% and 15.5%, respectively. Additionally, the firm's improved skill mix and access to a superior cost of capital enable aggressive and accretive capital deployment, reinforcing its potential for sustained organic growth.

Bears say

American Healthcare REIT Inc. exhibits a declining leverage ratio, having reduced its net debt to gross asset value from 42.2% to 31.1% over the past year, which may indicate improved financial stability; however, the company continues to face significant risks related to tenant performance and regional economic conditions. The net debt to annualized EBITDA ratio has also improved, dropping from 5.1x to 3.5x in the same period, yet this metric suggests that the reliance on debt remains a concern as it highlights the potential vulnerability of cash flow in varied regulatory or economic climates. Furthermore, with the anticipated lower Medicaid rates in certain markets and the associated earnings headwinds, the REIT's overall growth prospects may be jeopardized, adversely affecting its ability to meet earnings expectations in future periods.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.